Atherosclerotic cardiovascular disease screening and management protocols among adult HIV clinics in Asia.

Boettiger, D C; Law, M G; Ross, J; Huy, B V; Heng, Bsl; Ditangco, R; Kiertiburanakul, S; Avihingsanon, A; Cuong, D D; Kumarasamy, N; Kamarulzaman, A; Ly, P S; Yunihastuti, E; Parwati Merati, T; Zhang, F; Khusuwan, S; Chaiwarith, R; Lee, M P; Sangle, S; Choi, J Y; ... (2020). Atherosclerotic cardiovascular disease screening and management protocols among adult HIV clinics in Asia. Journal of virus eradication, 6(1), pp. 11-18. Mediscript

Preview

Text Boettiger JVirusErad 2020 .pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (227kB) | Preview

Objectives

Integration of HIV and non-communicable disease services improves the quality and efficiency of care in low- and middle-income countries (LMICs). We aimed to describe current practices for the screening and management of atherosclerotic cardiovascular disease (ASCVD) among adult HIV clinics in Asia.

Methods

Sixteen LMIC sites included in the International Epidemiology Databases to Evaluate AIDS - Asia-Pacific network were surveyed.

Results

Sites were mostly (81%) based in urban public referral hospitals. Half had protocols to assess tobacco and alcohol use. Protocols for assessing physical inactivity and obesity were in place at 31% and 38% of sites, respectively. Most sites provided educational material on ASCVD risk factors (between 56% and 75% depending on risk factors). A total of 94% reported performing routine screening for hypertension, 100% for hyperlipidaemia and 88% for diabetes. Routine ASCVD risk assessment was reported by 94% of sites. Protocols for the management of hypertension, hyperlipidaemia, diabetes, high ASCVD risk and chronic ischaemic stroke were in place at 50%, 69%, 56%, 19% and 38% of sites, respectively. Blood pressure monitoring was free for patients at 69% of sites; however, most required patients to pay some or all the costs for other ASCVD-related procedures. Medications available in the clinic or within the same facility included angiotensin-converting enzyme inhibitors (81%), statins (94%) and sulphonylureas (94%).

Conclusion

The consistent availability of clinical screening, diagnostic testing and procedures and the availability of ASCVD medications in the Asian LMIC clinics surveyed are strengths that should be leveraged to improve the implementation of cardiovascular care protocols.

Interest & Impact

Downloads

251 since deposited on 07 Apr 2020
20 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item